Abstract
"Blue toe" syndrome is a relatively rare ischemic disorder produced by occlusion of small blood vessels with fragments of atherosclerotic plaques composed of cholesterol crystals, fatty acids and calcium. It can occur as a complication after endovascular procedures, usually performed on the infra-renal segment of abdominal aorta, as well as in the patients who were under treatment with oral anticoagulant therapy. Hyperbaric oxygen therapy (HBOt) is inhaling 100% oxygen under carefully controlled elevated pressure conditions. In Zemun Clinical Hospital, a patient who presented with "blue toe" syndrome, has been treated with HBOt. After the completion of HBOt course, there was an almost complete regression of ischemic changes.
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Reference21 articles.
1. Chinsakchai, K., et al., Outcomes of abdominal aortic aneurysm with aortic neck thrombus after endovascular abdominal aortic aneurysm repair. J Med Assoc Thai, 2014. 97(5): p. 518-24.;
2. Quinones, A. and M. Saric, The cholesterol emboli syndrome in atherosclerosis. Curr Atheroscler Rep, 2013. 15(4): p. 315.;
3. Popov, P., et al., ["Blue-toe" syndrome as a possible complication of the abdominal aortic aneurysm: a report of two cases].Srp Arh Celok Lek, 2014. 142(3-4): p. 229-32.;
4. Feder, W. and R. Auerbach, "Purple toes": an uncommon sequela of oral coumarin drug therapy. Ann Intern Med, 1961. 55: p. 911-7.;
5. Karmody, A.M., et al., "Blue toe" syndrome. An indication for limb salvage surgery. Arch Surg, 1976. 111(11): p. 1263-8.;